Cargando…
Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity
Background: Cisplatin is an extensively used anti-neoplastic agent for the treatment of various solid tumors. However, a high incidence of severe ototoxicity is accompanied by its use in the clinic. Currently, no drugs or therapeutic strategies have been approved for the treatment of cisplatin-induc...
Autores principales: | Chen, Yuming, Gu, Jiayi, Liu, Jian, Tong, Ling, Shi, Fuxin, Wang, Xiaoqin, Wang, Xueling, Yu, Dehong, Wu, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559256/ https://www.ncbi.nlm.nih.gov/pubmed/31239676 http://dx.doi.org/10.2147/IJN.S195336 |
Ejemplares similares
-
Current Strategies to Combat Cisplatin-Induced Ototoxicity
por: Yu, Dehong, et al.
Publicado: (2020) -
A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration
por: Sun, Changling, et al.
Publicado: (2015) -
An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity
por: Gu, Jiayi, et al.
Publicado: (2022) -
Effects of polyethylene glycol content on the properties of a silk fibroin/nano-hydroxyapatite/polyethylene glycol electrospun scaffold
por: Qi, Qi, et al.
Publicado: (2019) -
Liquid Crystalline Nanoparticles Conjugated with Dexamethasone Prevent Cisplatin Ototoxicity In Vitro
por: Valente, Filippo, et al.
Publicado: (2022)